Inhaled corticosteroids in COPD.

Inhaled corticosteroids in COPD.

Podrobná bibliografie
Hlavní autoři:	Brightling, C, Pavord, I
Médium:	Journal article
Jazyk:	English
Vydáno:	1999

Podobné jednotky

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
Autor: Saha, S, a další
Vydáno: (2006)

Inhaled corticosteroids in COPD (multiple letters) [1]
Autor: Hart, S, a další
Vydáno: (1999)

Inhaled glucocorticoids and COPD exacerbations.
Autor: Brightling, C, a další
Vydáno: (2015)

Minimising inhaled corticosteroids for COPD
Autor: Benji Heran, a další
Vydáno: (2024-12-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Autor: Siddiqui, S, a další
Vydáno: (2018)

The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
Autor: Russell, R, a další
Vydáno: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Autor: Siddiqui SH, a další
Vydáno: (2018-11-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
Autor: Holly R. Keir, a další
Vydáno: (2021-09-01)

How inhaled corticosteroids target inflammation in COPD
Autor: Simon Lea, a další
Vydáno: (2023-10-01)

Rational use of inhaled corticosteroids for the treatment of COPD
Autor: Jennifer K. Quint, a další
Vydáno: (2023-07-01)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
Autor: Berry, M, a další
Vydáno: (2007)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Autor: Green, R, a další
Vydáno: (2006)

Reply to: inhaled corticosteroids and adult asthma
Autor: Beasley, R, a další
Vydáno: (2019)

Counterpoint: Should an attempt be made to withdraw inhaled corticosteroids in all patients with stable GOLD 3 (30% ≤ FEV1 < 50% predicted) COPD? No.
Autor: Pavord, I
Vydáno: (2018)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
Autor: Green, R, a další
Vydáno: (2002)

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
Autor: Ricardo G. Figueiredo, a další
Vydáno: (2022-08-01)

The dose of inhaled corticosteroids in patients with COPD: when less is better
Autor: Izquierdo JL, a další
Vydáno: (2018-10-01)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
Autor: Koehorst-ter Huurne K, a další
Vydáno: (2016-07-01)

COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
Autor: Ozcakir S, a další
Vydáno: (2020-10-01)

Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
Autor: Liu SF, a další
Vydáno: (2016-07-01)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
Autor: Cheng S, a další
Vydáno: (2017-07-01)

Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short
Autor: Tantucci C, a další
Vydáno: (2020-04-01)

Prevalence and clinical features of asthma-COPD overlap in patients with COPD not using inhaled corticosteroids
Autor: Kuniaki Hirai, a další
Vydáno: (2021-01-01)

Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
Autor: Soltani A, a další
Vydáno: (2016-09-01)

Biomarkers predicting response to corticosteroid therapy in asthma.
Autor: Brightling, C, a další
Vydáno: (2005)

Asthma progression and mortality: The role of inhaled corticosteroids
Autor: O'Byrne, P, a další
Vydáno: (2019)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
Autor: Antonio Oliver, a další
Vydáno: (2021-01-01)

Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment
Autor: Lucie Blais, a další
Vydáno: (2004-01-01)

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
Autor: Miravitlles M, a další
Vydáno: (2022-01-01)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
Autor: Cataldo D, a další
Vydáno: (2018-07-01)

Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
Autor: Koehorst-ter Huurne K, a další
Vydáno: (2018-09-01)

Non-eosinophilic corticosteroid unresponsive asthma.
Autor: Pavord, I, a další
Vydáno: (1999)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
Autor: Janson C, a další
Vydáno: (2017-10-01)

Prednisolone response in patients with COPD.
Autor: Pavord, I, a další
Vydáno: (2004)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
Autor: Bafadhel, M, a další
Vydáno: (2009)

Inhaled Corticosteroids
Autor: Peter J. Barnes
Vydáno: (2010-03-01)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
Autor: Bloom CI, a další
Vydáno: (2020-04-01)

Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary
Autor: Amnon Ariel, a další
Vydáno: (2023-11-01)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
Autor: Mario Cazzola, a další
Vydáno: (2023-07-01)

A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Autor: Smit Patel, a další
Vydáno: (2022-07-01)